Gastrointestinal

Clinical Trial NameClinical Trial Full TitlePrincipal InvestigatorProject site statusClinical trials gov number
(CCTG) CO.21 / CHALLENGEA Phase III Study of the Impact of a Physical Activity Program on Disease-Free Survival in Patients With High Risk Stage II or Stage III Colon Cancer: A Randomized Controlled Trial (CHALLENGE)Dr John GoffinSuspended/On holdNCT00819208
(CCTG) PAC.3 / ALLIANCE A021806A Phase III Trial of Perioperative versus Adjuvant Chemotherapy for Resectable Pancreatic CancerDr Pablo SerranoOpen to recruitmentNCT04340141
(Deciphera) DCC-2618-03-003 / INSIGHTAn International, Phase 3, Randomized, Multicenter, Open label Study of Ripretinib vs Sunitinib in Patients with Advanced Gastrointestinal Stromal Tumor (GIST) with KIT Exon 11 and Co-occurring KIT Exons 17 and/or 18 Mutations Who Were Previously Treated with ImatinibDr Kevin ZbukOpen to recruitmentNCT05734105
(Roche) CO44668 / IMbrave152A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING ATEZOLIZUMAB AND BEVACIZUMAB, WITH AND WITHOUT TIRAGOLUMAB, IN PATIENTS WITH UNTREATED LOCALLY ADVANCED OR METASTATIC HEPATOCELLULAR CARCINOMA.Dr Brandon MeyersOpen to recruitmentNCT05904886
(Roche) MO42541 / IMbrave251A PHASE III, OPEN-LABEL, RANDOMIZED STUDY OF ATEZOLIZUMAB WITH LENVATINIB OR SORAFENIB VERSUS SORAFENIB OR LENVATINIB ALONE IN HEPATOCELLULAR CARCINOMA PREVIOUSLY TREATEDWITH ATEZOLIZUMAB AND BEVACIZUMABDr Brandon MeyersOpen to recruitmentNCT04770896
OCOG-2021-ADVANCE HCCNeoadjuvant Combination of Atezolizumab/Bevacizumab Versus Neoadjuvant Radiation Therapy Prior to Hepatectomy in Hepatocellular Carcinoma with Portal Vein Tumour Thrombus (ADVANCE HCC)Dr Brandon MeyersSuspended/On holdNCT05137899
Download PDF